======= IARS =======
== Gene Information ==
* **Official Symbol**: IARS1
* **Official Name**: isoleucyl-tRNA synthetase 1
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=3376|3376]]
* **UniProt**: [[https://www.uniprot.org/uniprot/P41252|P41252]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=IARS&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20IARS|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/600709|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Catalyzes the specific attachment of an amino acid to its cognate tRNA in a 2 step reaction: the amino acid (AA) is first activated by ATP to form AA-AMP and then transferred to the acceptor end of the tRNA. {ECO:0000269|PubMed:8052601}.
|Anticodon 1|
|tRNA-synt 1|
|tRNA-synt 1g|
|isoleucine-tRNA ligase activity|
|isoleucyl-tRNA aminoacylation|
|aminoacyl-tRNA synthetase multienzyme complex|
|aminoacyl-tRNA editing activity|
|aminoacyl-tRNA metabolism involved in translational fidelity|
|regulation of translational fidelity|
|GTPase binding|
|tRNA aminoacylation for protein translation|
|tRNA aminoacylation|
|amino acid activation|
|tRNA binding|
|osteoblast differentiation|
|tRNA metabolic process|
|ossification|
|cellular amino acid metabolic process|
|translation|
|peptide biosynthetic process|
|ncRNA metabolic process|
|amide biosynthetic process|
|peptide metabolic process|
|cellular amide metabolic process|
|carboxylic acid metabolic process|
|oxoacid metabolic process|
|organic acid metabolic process|
|organonitrogen compound biosynthetic process|
|ATP binding|
|cellular nitrogen compound biosynthetic process|
|RNA metabolic process|
|cellular macromolecule biosynthetic process|
|small molecule metabolic process|
|macromolecule biosynthetic process|
|membrane|
|gene expression|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp514|Phorbol-12-myristate-13-acetate 0.57μM R08 exp514]]|-1.76|
|[[:results:exp65|Mubritinib 0.2μM R02 exp65]]|-1.7|
|[[:results:exp165|RO-3306 3 to 4μM on day4 R04 exp165]]|1.73|
|[[:results:exp272|CHIR-124 0.04μM R06 exp272]]|1.75|
|[[:results:exp28|Pimelic-diphenylamide-106 5μM R00 exp28]]|1.79|
|[[:results:exp19|Etoposide 1μM R00 exp19]]|1.97|
|[[:results:exp85|UM0129480 7μM R02 exp85]]|2.05|
|[[:results:exp3|Actinomycin-D 0.001μM R00 exp3]]|2.54|
|[[:results:exp2|5-Fluorouracil 20μM R00 exp2]]|2.6|
^Gene^Correlation^
|[[:human genes:h:hars|HARS]]|0.598|
|[[:human genes:m:mars|MARS]]|0.448|
|[[:human genes:m:meaf6|MEAF6]]|0.425|
Global Fraction of Cell Lines Where Essential: 709/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|1/1|
|909776.0|1/1|
|bile duct|27/28|
|blood|28/28|
|bone|26/26|
|breast|30/33|
|central nervous system|55/56|
|cervix|4/4|
|colorectal|16/17|
|esophagus|11/13|
|fibroblast|1/1|
|gastric|16/16|
|kidney|19/21|
|liver|20/20|
|lung|73/75|
|lymphocyte|15/16|
|ovary|26/26|
|pancreas|24/24|
|peripheral nervous system|15/16|
|plasma cell|14/15|
|prostate|1/1|
|skin|24/24|
|soft tissue|9/9|
|thyroid|2/2|
|upper aerodigestive|19/22|
|urinary tract|29/29|
|uterus|5/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 247
* **Expression level (log2 read counts)**: 9.14
{{:chemogenomics:nalm6 dist.png?nolink |}}